On October 30 HRSA announced a 340B Rebate Pilot would take effect on January 1, 2026. Under this pilot, FQHCs must pay the full “sticker price” for the ten drugs subject to Medicare price negotiations starting in 2026. The FQHC must then wait until the drug is dispensed, to apply on a manufacturer-funded platform for a rebate, and wait for the rebate to be paid, “floating” the upfront cost of the drug throughout. If implemented as planned this pilot will lead to widespread reductions of services, disruptions to patient care, and poorer health outcomes at FQHCs.
Our national colleagues have been working to develop federal legislation to exempt CHCs from the 340B rebate pilot and now we’re ready to ask you and your CHC to launch a full-scale advocacy effort to get this exemption enacted into law.
Please use the TAKE ACTION link and follow the guided actions to
Email both your House Representative and Senator
and then use the Call script to call their offices TODAY!
340B Rebate Pilot: CHC Exemption Bill
This bill would exempt FQHCs from a 340B rebate model, in 2026 and at any future point. We need all our MA CHC advocates to email and call their federal Members of Congress to express their support for this legislation and ask that they sign-on as a cosponsor.
